By: Murray McLoud Background on Measles and the MMR Vaccine Measles is an extremely contagious virus that spreads via air droplets after an infected individual breathes, sneezes, or coughs.[1] Contracting measles does not require close contact with an infected individual—instead, it can occur by breathing in contaminated air droplets or touching an infected surface.[2] To […]| Wake Forest Law Review
By: Madison Doser On Friday, March 14, President Trump issued an Executive Order eliminating the Institute of Museum and Library Services (“IMLS”) as part of his continued effort to reduce the size of the federal bureaucracy.[1] This executive order effectively cut seven government entities that the President determined were unnecessary.[2] The flurry of executive orders passed […]| Wake Forest Law Review
15 Wake Forest L. Rev. Online 1 Nicholas R. Rader Introduction Corporations may, as a result of their operations, incur substantial contingent liabilities that diminish their enterprise value.[1] In some cases, these contingent liabilities take the form of mass tort judgments, which threaten to drag corporations into protracted, complex litigation in diverse forums with potentially […]| Wake Forest Law Review
By: Will Boyce Background The human body is made up of water, proteins, fats, and . . . per- and polyfluoroalkyl substances? These chemicals, or PFAS for short, are a group of nearly 15,000 synthetically made chemicals known for their strong resistance to heat and other substances, earning them the title “forever chemicals.”[1] And while […]| Wake Forest Law Review
By: Sam Zeliff History of the “Sensitive Area” Policy “Sensitive areas,” or “protected areas,” are designated locations where the government has prohibited immigration enforcement activities.[1] These areas may include schools, healthcare facilities, places of worship, and social service establishments.[2] This is not an exhaustive list, and law enforcement officers have previously been directed to exercise […]| Wake Forest Law Review
By Kaitlyn Snyder On November 19, 2024, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) issued a Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, extending the flexibilities through December 31, 2025.[1] The third—and supposedly final—temporary extension aims to give the DEA and HHS enough […]| Wake Forest Law Review
